Home - Syndax

Determined to realize a future in which people with cancer live longer and better than ever before.

Clinical Trials

05.11.22

Syndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day

05.09.22

Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update

05.02.22

Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022

03.04.22

Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)